An Unprecedented Opportunity

“4D” GLP-1 Combinations For Cardio-Renal-Metabolic Diseases

De-Risked

Data Rich

Differentiated

Documented FTO & IP

Pipeline Assets Include: 2 Long-Acting GLP-1r agonists, 2 Long-Acting Amylin agonists, Long-Acting PYY and Long-Acting Glucagon

New Website & Corporate News Coming Soon…